MYC and colorectal carcinoma: Molecular profiling of human CRC revealed enrichment of AHCY expression in consensus molecular subtype (CMS) 2 (Extended Data Fig. 5b), which is characterized by WNT and MYC activation, and accounts for 37% of CRCs19.